These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Nevirapine/didanosine/lamivudine once daily in HIV-1-infected intravenous drug users.
    Author: Staszewski S, Haberl A, Gute P, Nisius G, Miller V, Carlebach A.
    Journal: Antivir Ther; 1998; 3 Suppl 4():55-6. PubMed ID: 10723511.
    Abstract:
    Human immunodeficiency virus (HIV)-infected, active intravenous drug users received once-daily therapy consisting of a combination of didanosine (2',3'-dideoxyinosine or DDI), lamivudine [(-)-beta-L-2',3'-dideoxy-3'-thiacytidine or 3TC] and nevirapine. Preliminary results for the first 24 weeks show that the regimen provides potent immunological and antiviral effects.
    [Abstract] [Full Text] [Related] [New Search]